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1. Introduction 
Local anaesthetics uch as nupercaine have been 
shown to have a protective action on the structure 
and energy-linked functions of rat liver mitochondria 
during incubation at 30°C or prolonged storage at 0°C 
[ 1.21. This action has been attributed to the inhibition 
of endogenous Ca’+-activated phospholipase A by the 
local anaesthetics [3,4], These observations have 
provided a logical basis for the incorporation of 
nupercaine in the medium for experiments on mito- 
chondrial Ca*+ uptake [5] in order to overcome the 
problem of mitochondrial fragility encountered in 
such experiments 161. Local anaesthetics appear to 
have other actions on mitochondria such as competi- 
tion for cation binding sites [7] and stimulation of 
Ca*+ uptake [8,9]. 
Although rat liver mitochondria are usually con- 
sidered to have a low permeability to most anions, 
other than by highly specific carriers [IO] , rat liver 
mitochondria have been reported [ 1 l] to become 
permeable to Cl- at high pH (pH 8-9) and con- 
ditions reported [ 121 under which beef heart 
mitochondria become permeable to Br-, succinate, 
fumarate and citrate as well as Cl-. We have reported 
[ 131 investigations of the anion permeability of rat 
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liver mitochondria and rationalisation of the observa- 
tions in terms of a pH-dependent anion-conducting 
pore in the mitochondrial inner membrane. This pore 
appears to open progressively with increasing pH over 
the range pH 779 and also depends on the presence 
of free Ca’+ inside the mitochondria. 
This paper reports our finding that the anion perme- 
ability of mitochondria at alkaline pH IS inhibited by 
several ocal anaesthetics in contrast to their effects 
or lack of effects on N0.3-, phosphate and ribose 
transport. 
2. Materials and methods 
Butacaine sulphate and tetracaine hydrochloride 
were obtained from Sigma (London) Chem. Co., 
procaine hydrochloride and ribose from BDH Chem. 
Ltd, nupercaine (cinchocaine hydrochloride) was a 
gift from CIBA Labs, Horsham. Ammonium isethio- 
nate was obtained from Stuart Kinney Co., Hepes 
from Hopkin and Williams Ltd, FCCP from Boehringer 
Corp. (London) Ltd. Other reagents were of A.R. or 
biochemical grade. 
Mitochondria were prepared and their protein con- 
centration assayed essentially as in [ 141 except that 
0.5 mM EGTA was included in the homogenisation 
and first wash media. Light scattering measurements 
were made in a continuously stirred cuvette thermo- 
statted at 25°C as in [14] ; 4.0 ml medium contained 
1.5 pg each of rotenone and antimycin: mitochondria, 
152.0 mg protein, were added to give an initial 
absorbance of 0.75 to 0.95. (The amount of mrtochon- 
dria added was constant for any set of experiments 
and batch of mitochondria.) 
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3. Results 
The electrogenic uniport mode of movement of 
Cl- across the mitochondrial membrane at pH 8 is 
shown by the rapid decrease in light scattering 
produced by adding uncoupler, FCCP, to the mito- 
chondria suspended in an NH+Cl medium, fig.l(A). 
The protons conducted by the uncoupler balance the 
pH difference produced by entry of NH, and the 
electrical charge difference produced by Cl- uniport 
so that the overall process is equivalent to entry of 
NH,Cl which thus fails to provide osmotic balance, 
and this in turn allows the mitochondria to swell and 
thus scatter less light. When a local anaesthetic such 
as nupercaine is added to mitochondria suspended in 
an NH4C1 medium there is a small, virtually instan- 
taneous, decrease in light scattering and a slight 
stimulation of the rate of decrease of light scattering, 
fig.l(b). However, fig.l(b-e) also show that the rate 
of light scattering decrease produced by addition of 
uncoupler is markedly inhibited by the presence of 
nupercaine. This inhibition occurs rapidly and is 
observed regardless of whether the nupercaine is added 
before, fig.l(b,d), or after, fig.l(c,d), the uncoupler. 
The virtually immediate onset of inhibition shows that 
it does not involve inhibition of a phospholipase since 
such action would prevent a time-dependent change 
Fig.1. Inhibition of Cl- entry by nupercaine. In all cases the 
medium was 0.1 M NH,Cl adJusted to pH 7.9 with NH, solu- 
tion. Experiments were initiated by addition of mitochondria 
as shown by the vertical rise at the left of each trace, N marks 
the addition of nupercaine to 0.6 mM final cone, F marks the 
addition of FCCP to 5 UM final cont. (a) No nupercaine added. 
(b) Nupercaine added 15 s after the mitochondria, FCCP 
added 15 s after the nupercaine. (c) Nupercaine added 15 s 
after FCCP. (d) Nupercaine added 2 s prior to FCCP. 
(e) Nupercaine added 2 s after FCCP. Other conditions as in 
section 2. 
in permeability. The procedure of adding the local 
anaesthetic 15 s after the mitochondria and 15 s 
before uncoupler, as shown in fig.l(b) was adopted in 
order to observe the effect of addition and also because 
some local anaesthetics produced progressive damage 
to the mitochondria when added at high concentra- 
tion. 
Using this procedure experiments were carried out 
with a range of concentrations of butacaine, nupercaine, 
procaine and tetracaine, the results of which are presented 
as Dixon plots in fig.2. All inhibited Cl- entry, the 
concentrations producing 50% inhibition being: nuper- 
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Fig.2. Dixon plot of the inhibition of Cl- entry by local 
anaesthetics. Experimental conditions were as in fig.1, the 
order and timing of additions being as in fig.l(b). Inhibition 
was estimated from initial rates after the addition of FCCP, 
“i rate with inhibitor present, v. rate in absence of inhibitor. 
(A) Nupercaine; (o) tetracame; (0) butacaine; (v) procaine. 
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Fig.3. Inhibition by tetracame of the entry of isethionate, 
fumarate and succinate anions at alkaline pH. Conditions 
and order of additions as fig.l(b). (a,b) Ammonium 
isethionate, 100 mM (pH 8.0). (c,d) Ammonium fumarate, 
85 mM (pH 8.2). (e,f) Ammonium succinate, 85 mM (pH 8.5). 
T marks the addition of tetracaine to 0.5 mM final cont., 
F the addition of FCCP to 5 nM final cont. 
Caine, 0.2 mM; tetracaine, 0.4 mM; butacaine, 0.7 mM; 
procaine, 17 mM. 
The entry of other anions by uniport at alkaline 
pH is also inhibited by local anaesthetics and as 
examples the inhibition of isethionate, fumarate 
and succinate entry by tetracaine are shown in tig.3. 
In contrast the entry of N03- is only partially 
inhibited, fig,4(a,b), N03- appears to have two modes 
of uniport entry. the alkaline pH-dependent pore and 
another process operative at pH 7 and below [ 131, 
and only the former is inhibited by local anaesthetics. 
Figure 4 also shows that the phosphate-hydroxide 
exchanger carrier is insensitive to tetracaine (c-e) 
while the entry of ribose is stimulated (f,g). 
Fig.4. Effect of tetracaine on NO,- entry,phosphate hydroxide 
exchange and ribose entry. Conditions as in tig.l. (a,b) Ammo- 
nium nitrate 0.1 M, (pH 8.0), T indicates addition of tetra- 
caine to 0.5 mM, F the addition of FCCP to 5 PM. (c-e) 
Ammonium phosphate, 80 mM (pH 7.5): (c) tetracaine 
absent; (d) 0.5 mM tetracaine present; (e) 1.0 mM tetracaine. 
present. (f,g) Ribose, 230 mM with 10 mM Hepes-KOH 
buffer (pH 8.0): (f) tetracame absent; (g) 0.5 mM tetracaine 
present. 
4. Discussion 
The distinction between the inhibition of the 
pH-dependent anion uniport and the lack of marked 
effect on N03- transport and phosphate-hydroxide 
exchange together with the stimulation of ribose 
entry suggests that the interaction of local anaesthet- 
its with the pH-dependent anion conduction system 
is more specific than some general effect on mem- 
brane stability produced by dissolution of the anaes- 
thetic in the lipid of the membrane. Furthermore, 
simple adsorption of the local anaesthetics would 
make the surface charge more positive (or less nega- 
tive) and this would be expected to increase rather 
than decrease the anion permeability as discussed [ 151 
where the inhibition of chloride transport in red blood 
cells by local anaesthetics was investigated. 
The apparent involvement of free intramitochondrial 
Ca” in the anion conduction system [ 131, considered 
together with the observation [7] of competition 
between local anaesthetics and Ca” for cation binding 
sites and the observation [8,9] of Ca2+ uptake stimu- 
lation by butacaine, may indicate that displacement 
of Ca2+ from an activating site is involved in the 
inhibition by local anaesthetics. 
These observations indicate that addition of local 
anaesthetics to the medium for their protective action 
on mitochondria must be viewed with caution for, while 
there may be an inhibition of endogenous Cazc-activated 
phospholipase, in short-term experiments reduction 
of fragility may involve inhibition of anion movement 
and these effects on anion movement may well affect 
the apparent charge stoichiometry of Ca2’ transport. 
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